Regeneron Pharmaceuticals, Inc.
Cash Flow Statement
| Line Item | FY2009 | FY2008 |
|---|---|---|
| Operating Activities | ||
| Net Income | $-67.8M | $-79.1M |
| Depreciation & Amortization | $14.2M | $11.3M |
| Depreciation | — | — |
| Amortization | — | — |
| Stock-Based Compensation | $31.3M | — |
| Net Cash from Operating Activities | $-69.9M | $-89.1M |
| Investing Activities | ||
| Capital Expenditures | $97.3M | $34.9M |
| Business Acquisitions | — | — |
| Net Cash from Investing Activities | $-2.1M | $30.8M |
| Financing Activities | ||
| Dividends Paid | — | — |
| Stock Repurchases | — | — |
| Net Cash from Financing Activities | $31.4M | $-192.9M |
| Net Change in Cash | $-40.7M | $-251.1M |
| Free Cash Flow | $-167.3M | $-123.9M |